Intervention not reported
Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
1 finding from 1 review
Intervention not reported
Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
1 finding from 1 review
Intervention not reported
Surgical site infection within 30 days in trials with low risk of bias (14 days to 30 days) · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in surgical site infection within 30 days in trials with low risk of… (low certainty).
1 finding from 1 review
Intervention not reported
Surgical site infection within 30 days, irrespective of risk of bias (14 days to 30 days) · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in surgical site infection within 30 days, irrespective of risk of bias… (low certainty).
1 finding from 1 review
Intervention not reported
Respiratory insufficiency · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in respiratory insufficiency (moderate certainty).
1 finding from 1 review
Intervention not reported
Death · people with acute ischaemic stroke
The intervention showed no clear difference in death (moderate certainty).
1 finding from 1 review
Nasal obstruction/severe mucus production · children with acute lower respiratory tract infections
Nasal prongs may leads to lower nasal obstruction/severe mucus production compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Nose ulceration or bleeding · children with acute lower respiratory tract infections
Nasal prongs showed no clear difference in nose ulceration or bleeding compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Fighting/discomfort in the first 24 hours · children with acute lower respiratory tract infections
Nasal prongs showed no clear difference in fighting/discomfort in the first 24 hours compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Death during treatment · children with acute lower respiratory tract infections
Nasal prongs showed no clear difference in death during treatment compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Exacerbation of IBD · IBD patients
Etoricoxib showed no clear difference in exacerbation of IBD compared with placebo (low certainty).
1 finding from 1 review
Exacerbation of ulcerative colitis · Patients with quiescent ulcerative colitis
Celecoxib showed no clear difference in exacerbation of ulcerative colitis compared with placebo (low certainty).
1 finding from 1 review
GI adverse events · Patients with quiescent ulcerative colitis
Celecoxib showed no clear difference in GI adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Death at any time in trial period case mortality count · Patients with acute traumatic brain injury
The intervention probably leads to lower death at any time in trial period case mortality count (moderate certainty).
1 finding from 1 review
Intervention not reported
Favourable outcome GOS <9 or similar · Patients with acute traumatic brain injury
The intervention showed no clear difference in favourable outcome GOS <9 or similar; GRADE not reported.
1 finding from 1 review
Intervention not reported
Mean improvement in pure‐tone average hearing threshold across all frequencies Decibels Scale from: 0 to 120 · patients with idiopathic sudden sensorineural hearing loss or tinnitus
1 finding from 1 review
Intervention not reported
More than 50% improvement in pure‐tone average threshold Risk ratio · patients with idiopathic sudden sensorineural hearing loss or tinnitus
The intervention showed no clear difference in more than 50% improvement in pure‐tone average threshold Risk ratio (moderate certainty).
1 finding from 1 review
Intervention not reported
More than 25% improvement in pure‐tone average threshold Risk ratio · patients with idiopathic sudden sensorineural hearing loss or tinnitus
The intervention probably leads to higher more than 25% improvement in pure‐tone average threshold Risk ratio (moderate certainty).
1 finding from 1 review
change in respiratory distress score at 30 minutes Scale from: 0 to 13. · patients with acute bronchiolitis in children up to three years of age
2 findings from 1 review
change in respiratory distress score at 30 minutes Scale from: 0 to 13. · patients with acute bronchiolitis in children up to three years of age
2 findings from 1 review